The blood coagulation factor market is experiencing consistent growth due to the increasing prevalence of bleeding disorders, advancements in recombinant therapies, and rising awareness regarding early diagnosis and treatment. Blood coagulation factors are essential therapeutic products used to manage inherited and acquired coagulation disorders, particularly hemophilia and other rare bleeding...
SPARK Website
عربي